Effectiveness of Using (Vanish XT) in Prevention of Occlusal Caries: a RCT
Effectiveness of Using a Light Curable Resin Modified Glass Ionmer Cement Varnish (Vanish XT) in Prevention of Occlusal Caries: a Randomized Controlled Clinical Trial
1 other identifier
interventional
84
1 country
1
Brief Summary
Despite the continuous effort to prevent and treat dental caries, it continues to be one of the most common chronic diseases in both children and adults. Prevention and minimally intervention treatment by early detection of the lesion are becoming the new philosophy in managing dental caries. The prevalence of pit and fissure caries was found to be 90% of all dental caries in permanent molars. Moreover, the risk of caries development is higher soon after the tooth had erupted. The purpose of the current study is; to evaluate the effectiveness of a resin-modified glass ionmer cement (Vanish XT) varnish in the prevention of occlusal caries and compare it to a fluoride varnish in newly erupted first permanent molars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 6, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedOctober 8, 2020
October 1, 2020
1 year
October 6, 2020
October 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
caries development
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
3 months
caries development
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
6 months
caries development
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
12 months
caries development
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
18 months
Study Arms (2)
Study group
EXPERIMENTALThis is the study group; it will consist of 84 first permanent molars. These molars will be sealed using light curing resin-modified glass ionomer varnish (ClinproTM XT Vanish, 3M ESPE, Dental Products, St. Paul, MN, USA). reapplication will be done after 3,6, 12, and 18 months.
Control group
OTHERThis group will consist of 84 first permanent molars. These molars will receive 5% Sodium Fluoride (NaF) with Tri-Calcium Phosphate topical varnish (Vanish White Varnish, 3M ESPE, Dental Products, St. Paul, MN, USA). These molars will serve as a control group. reapplication will be done after 3,6, 12, and 18 months.
Interventions
Light curing resin-modified glass ionomer varnish (ClinproTM XT Vanish, 3M ESPE, Dental Products, St. Paul, MN, USA) will be used to seal 84 first permanent molars at baseline, 3, 6, 12 and 18 months.
5% Sodium Fluoride (NaF) with Tri-Calcium Phosphate topical varnish (Vanish White Varnish, 3M ESPE, Dental Products, St. Paul, MN, USA) will be used on 84 first permanent molars at baseline, 3, 6, 12 and 18 months.
Eligibility Criteria
You may qualify if:
- Healthy children having no history of any systemic condition.
- Children must have all four first permanent molar.
- Children must have at least one pair of contralateral newly erupted first permanent molars free from caries.
- Teeth with deep pits and fissures (at high risk for caries).
- These molars should be free of caries, restorations, sealants, fracture, hypoplasia, or cracks.
- High caries risk children.
You may not qualify if:
- Children whom their parents refused to sign the consent form.
- Children older than 9 years old.
- Medically compromised children.
- Children having discolored grooves, restored, caries, or hypoplastic first permanent molars.
- Children having proximal caries in first permanent molars.
- Children whose antagonist teeth were extracted or not erupted.
- Children with a known acrylate allergy.
- Uncooperative children.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King abulaziz University, Dental University Hospital
Jeddah, P.O Box 80209, 21589, Saudi Arabia
Related Publications (1)
Baik A, Alamoudi N, Felemban O, El-Housseiny A, Almabadi E, Baik K, Altuwirqi A, Masoud I. Prevention of occlusal caries using VanishTM XT: an 18-month follow-up randomized clinical trial. BMC Oral Health. 2024 Nov 1;24(1):1328. doi: 10.1186/s12903-024-05095-8.
PMID: 39487418DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Triple blinding. Because of the nature of the material, the investigator who will apply the material to the occlusal surfaces will not be blinded to the group allocation. However, the investigators who will perform the clinical visual examination and the radiographic examination will be blinded to which group the teeth they are evaluating belongs. In addition, the statistician will be blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- paediatric dentist specialist
Study Record Dates
First Submitted
October 6, 2020
First Posted
October 8, 2020
Study Start
February 1, 2019
Primary Completion
February 1, 2020
Study Completion
July 1, 2021
Last Updated
October 8, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share